Circumventing human limits in precision oncology: AI-enhanced tailoring of post-operative treatment for pancreatic ductal adenocarcinoma von Casalino, S., Zecchetto, C., Merz, V., Quinzii, A., Pietrobono, S., Melisi, D.

Volltext

Is There Room for Liposomal Irinotecan in Biliary Tract Cancer? A Meta-analysis of Randomised Trials von Merz, V, Messina, C, Zecchetto, C, Quinzii, A, Frisinghelli, M, Trentin, C, Salati, M, Caffo, O, Melisi, D

Volltext

TAK1-regulated expression of BIRC3 predicts resistance to preoperative chemoradiotherapy in oesophageal adenocarcinoma patients von Piro, G, Giacopuzzi, S, Bencivenga, M, Carbone, C, Verlato, G, Frizziero, M, Zanotto, M, Mina, M M, Merz, V, Santoro, R, Zanoni, A, De Manzoni, G, Tortora, G, Melisi, D

Volltext

Adipocytes sustain pancreatic cancer progression through a non-canonical WNT paracrine network inducing ROR2 nuclear shuttling von Carbone, C, Piro, G, Gaianigo, N, Ligorio, F, Santoro, R, Merz, V, Simionato, F, Zecchetto, C, Falco, G, Conti, G, Kamga, P T, Krampera, M, Di Nicolantonio, F, De Franceschi, L, Scarpa, A, Tortora, G, Melisi, D

Volltext

248 Fibroblast Growth Factor Receptor (FGFR)3 sustains acquired resistance to trastuzumab in gastric cancer patients von Piro, G, Carbone, C, Cataldo, I, Di Nicolantonio, F, Giacopuzzi, S, Boschi, F, Zanotto, M, Merz, V, Mina, M.M, Sbarbati, A, De Manzoni, G, Scarpa, A, Tortora, G, Melisi, D

Volltext

P-26 Is there room for nal-IRI in biliary tract cancer? von Merz, V., Messina, C., Zecchetto, C., Quinzii, A., Frisinghelli, M., Trentin, C., Salati, M., Caffo, O., Melisi, D.

Volltext

1620P A phase II study of perioperative nalirifox in patients with resectable pancreatic ductal adenocarcinoma (rPDAC): Survival update and biomarkers analysis of the NITRO trial von Melisi, D., Merz, V., Fazzini, F., Pietrobono, S., Zecchetto, C., Malleo, G., Landoni, L., Quinzii, A., Casalino, S., C. pesoni, Gaule, M., Casetti, L., D'Onofrio, M., Gabbrielli, A., Bernardoni, L., Milleri, S., Butturini, G., Scarpa, A., Salvia, R., Bassi, C.

Volltext

337P Real-life second-line therapies outcome in metastatic pancreatic cancer (mPDAC) patients previously treated with gemcitabine plus nab-paclitaxel (Gem-Nab): An Italian multicen... von Procaccio, L., Giordano, G., Barsotti, G., Zecchetto, C., Bergamo, F., Landriscina, M., Masucci, M., Di Paolo, G., De Vita, F., Gebbia, V., Mancino, A., Ricagno, G., Bianco, R., Noventa, S., Lo Re, G., Vasile, E., Sperotto, S., Casalino, S., Merz, V., Lonardi, S.

Volltext

Plasmatic CXCL8 is a marker for TGFß-activated kinase 1 (TAK1) activation which may predict resistance to nanoliposomal irinotecan (nal-IRI) in gemcitabine-refractory pancreatic ca... von Merz, V., Zecchetto, C., Santoro, R., Simionato, F., Piro, G., Sabbadini, F., Cavaliere, A., Casalino, S., Auriemma, A., Melisi, D.

Volltext

697P - Plasmatic CXCL8 is a marker for TGFß-activated kinase 1 (TAK1) activation which may predict resistance to nanoliposomal irinotecan (nal-IRI) in gemcitabine-refractory pancre... von Merz, V., Zecchetto, C., Santoro, R., Simionato, F., Piro, G., Sabbadini, F., Cavaliere, A., Casalino, S., Auriemma, A., Melisi, D.

Volltext

697PPlasmatic CXCL8 is a marker for TGFß-activated kinase 1 (TAK1) activation which may predict resistance to nanoliposomal irinotecan (nal-IRI) in gemcitabine-refractory pancreati... von Merz, V, Zecchetto, C, Santoro, R, Simionato, F, Piro, G, Sabbadini, F, Cavaliere, A, Casalino, S, Auriemma, A, Melisi, D

Volltext

57P Third-line chemotherapy in advanced biliary cancers (ABC): Pattern of care, treatment outcome and prognostic factors from a multicenter study von Rizzo, A., Salati, M., Merz, V., Messina, C., Ricci, A.D., Palloni, A., Frega, G., De Lorenzo, S., Caputo, F., Gelsomino, F., Spallanzani, A., Mollica, V., Abbati, F., Carotenuto, P., Pettorelli, E., Benatti, S., Luppi, G., Melisi, D., Dominici, M., Brandi, G.

Volltext

63P Multicentre match-paired analysis of advanced biliary cancer (ABC) long-term survivors: The BILONG study von Caputo, F., Gelsomino, F., Spallanzani, A., Pettorelli, E., Benatti, S., Ghidini, M., Grizzi, G., Ratti, M., Merz, V., Messina, C., Tonelli, R., Luppi, G., Melisi, D., Dominici, M., Salati, M.

Volltext

Bridging the equity gap in patient education: the biliary tract cancer BABEL project von Casolino, Raffaella, Braconi, Chiara, Prete, MG, González Romero, F, Castro, RE, Banales, JM, Cardinale, V, Morement, H, Milne, J, Krawczyk, M, Krupa, L, Anwar, MM, Poles, ES, Merz, V, Perra, T, Porcu, A, Megdanova, V, Popova, Y, Meneses-Medina, MI, Reyes Mondragón, AL, Burguete-Torres, A, Brandão Rego, I, Magalhães, J, Liz Pimenta, J, Silva, J, João Sousa, M, Custódio, S, Costa, T, Cojocaru, FD, Drug, VL, Hassan, SU, Ain Azam, NU, Kupcinskas, J, Kreivenaite, E, Morkunas, E, Nikolaieva, O, Calvisi, D, Evert, M, Terhuja, N, Das, A, Hoang, KD, Nguyen, HH, Evseev, V, Khuntikeo, N, Abdihamid, O, Mariamidze, E, Tsiklauri, K, Koyyala, VPB, Medisetty, P, Digumarti, L, Digumarti, RR, Konkalla, VLA, Mitra, S, Sud, R, Parikh, P, Gupta, SK, Sen, S, Chanda, S, das, D, Domadia, K, Goyal, P, Goyal, S, Dhamne, N, Acharya, PV, Jain, P, Sharma, M, War, GA, Singh, SR, Dodagoudar, C, Patnaik, RS, Mashahary, SS, Paul, R, Kannan, T, Goel, V, Patnaik, N, Jajodia, A, Pasricha, S, Gupta, M, Agarwal, C, Mondal, DK, BP, A, Joga, S, Mullapally, SK, Choudhary, P, Saini, R, Selvaraju, T, Pahwa, S, Durga, G, Maheshwari, U, Dhaka, S, Lindsay, S, Omar, A, La Casta Muñoa, A

Volltext

Development and Multicentre Validation of the Modena Score to Predict Survival in Advanced Biliary Cancers Undergoing Second-Line Chemotherapy von Salati, Massimiliano, Marcheselli, Luigi, Messina, Carlo, Merz, Valeria, Messina, Marco, Carotenuto, Pietro, Caputo, Francesco, Gelsomino, Fabio, Spallanzani, Andrea, Reggiani Bonetti, Luca, Caramaschi, Stefania, Luppi, Gabriele, Dominici, Massimo, Ghidini, Michele

Volltext

A circulating TH2 cytokines profile predicts survival in patients with resectable pancreatic adenocarcinoma von Melisi, D., Piro, G., Simionato, F., Carbone, C., Frizziero, M., Malleo, G., Zanini, S., Casolino, R., Santoro, R., Mina, M.M., Zecchetto, C., Merz, V., Scarpa, A., Bassi, C., Tortora, G.

Volltext

Abnormal p53 expression is rare in clinically localized human prostate cancer: Comparison between immunohistochemical and molecular detection of p53 mutations von Mottaz, Alain E., Markwalder, Regula, Fey, Martin F., Klima, Irena, Merz, Vincent W., Thalmann, George N., Ball, Roland K., Studer, Urs E.

Volltext

Transforming growth factor-beta 3 is expressed in nondividing basal epithelial cells in normal human prostate and benign prostatic hyperplasia, and is no longer detectable in prost... von Djonov, V, Ball, R K, Graf, S, Mottaz, A E, Arnold, A M, Flanders, K, Studer, U E, Merz, V W

Volltext

Financial Modeling, Actuarial Valuation and Solvency in Insurance von Wüthrich, Mario V, Merz, Michael

Volltext

The first horse herders and the impact of early Bronze Age steppe expansions into Asia von Damgaard, P. de B., Martiniano, R., Kamm, J., Moreno-Mayar, J.V., Kroonen, G.J., Peyrot, M., Barjamovic, G., Rasmussen, S., Zacho, C., Baimukhanov, N., Zaibert, V., Merz, V., Biddanda, A., Merz, I., Loman, V., Evdokimov, V., Usmanova, E., Hemphill, B., Seguin-Orlando, A., Yediay, F.E., Ullah, I., Sjögren, K.-G., Iversen, K.H., Choin, J., Fuente, C. de la, Ilardo, M., Schroeder, H., Moiseyev, V., Gromov, A., Polyakov, A., Omura, S., Senyurt, S.Y., Ahmad, H., McKenzie, C., Margaryan, A., Hameed, A., Samad, A., Gul, N., Khokhar, M.H., Goriunova, O.I., Bazaliiskii, V.I., Novembre, J., Weber, A.W., Orlando, L., Allentoft, M.E., Nielsen, R., Kristiansen, K., Sikora, M., Outram, A.K., Durbin, R., Willerslev, E.

Volltext bestellen